| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Phio Pharmaceuticals (NASDAQ:PHIO) through any online brokerage.
Other companies in Phio Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Phio Pharmaceuticals has a consensus price target of $10.67.
The stock price for Phio Pharmaceuticals (NASDAQ: PHIO) is $0.8899 last updated October 16, 2026 at 4:42 PM EDT.
There are no upcoming dividends for Phio Pharmaceuticals.
Phio Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Phio Pharmaceuticals.
Phio Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
